SlimGLO coaching
- Nutrition and habit education
- Movement resources
- Goal planning and monthly check-ins
- General skin-wellness routines
WOMEN’S WEIGHT-LOSS SUPPORT
Build a plan
you can live with.
Nutrition, movement, and accountability around your weight-management goals.
SUPPORT BEYOND A PRESCRIPTION
Practical habits.
Personalized guidance.
Your weight-management goals exist within a real life: meals, work, family, movement, and everything in between. SlimGLO helps you organize those everyday habits into a practical coaching plan.
- Personalized nutrition education and meal-planning habits
- Movement and strength education
- Monthly reflection and accountability
- Skin-wellness education within a whole-person approach
GLP-1 SUPPORT
A clear partnership
around your goals.
If medication is part of your care, your care team manages that treatment. SlimGLO focuses on coaching and everyday wellness education.
Your medical review
- Medical evaluation and treatment decisions
- Prescription eligibility and prescribing
- Medication dosing and medical monitoring
- Clinical questions and side-effect care
Enrollment does not guarantee a prescription, a specific amount of weight loss, or a particular medical outcome.
UNDERSTANDING GLP-1
Understand the treatment.
Build the habits around it.
General education for adults considering prescription weight-management care. Medical eligibility review is required before prescription treatment.
APPETITE & FULLNESS
What GLP-1 means
GLP-1 stands for glucagon-like peptide-1, a hormone involved in appetite and blood-sugar regulation. GLP-1 medicines act on these pathways to reduce hunger and food intake. They also slow stomach emptying and support glucose-dependent insulin release.
For eligible patients, prescription treatment can help with weight loss and maintaining that loss alongside nutrition and physical activity. Response varies; medication is not a guarantee of a particular weight or timeline.
SUPPORT BEYOND THE DOSE
What coaching adds
SlimGLO helps you organize meals, movement, skin-wellness routines, and monthly accountability around real life. Your plan emphasizes repeatable habits rather than a promised transformation.
- Personalized nutrition education and meal planning
- Movement and strength-habit education
- One monthly virtual coaching check-in
- Questions to take to your care team
SlimGLO wellness support does not replace medical follow-up. SLIMGLO START™ is $299/month and SLIMGLO MAX™ is $449/month. The listed price includes the stated medication, nutrition and lifestyle support, and a monthly wellness check-in, subject to medical eligibility and your program agreement.
KNOW THE DIFFERENCE
Similar goals.
Different medicines.
Semaglutide
Semaglutide activates GLP-1 receptors. Wegovy is a weight-management brand; Ozempic is a diabetes brand with different approved uses and dosing. Brand names, formulations, and indications are not interchangeable.
Tirzepatide
Tirzepatide acts on both GIP and GLP-1 receptors. Zepbound is a weight-management brand; Mounjaro is a diabetes brand. Your clinician considers your history, treatment goals, and the specific product.
Brand names are educational references, not a statement of SlimGLO stock or medication availability. Eligibility commonly includes obesity, or overweight with a weight-related condition; your clinician makes the assessment. GLP-1 medication is not a skin treatment.
TITRATION / GRADUAL DOSE ADJUSTMENT
Start low.
Adjust with your prescriber.
Titration means gradually adjusting a medicine’s dose. Initial doses help your body adapt; they are not necessarily the long-term dose. Gradual escalation helps reduce gastrointestinal side effects. Your prescriber reviews tolerability and response before changes.
Wegovy injection: initial escalation
- Weeks 1–4
- 0.25 mg once weekly
- Weeks 5–8
- 0.5 mg once weekly
- Weeks 9–12
- 1 mg once weekly
- Weeks 13–16
- 1.7 mg once weekly
Label example for initial injection escalation, not a personal prescription. Maintenance depends on the indication and formulation. The prescriber may delay escalation if a dose is not tolerated. Oral semaglutide uses a different schedule.
Zepbound: introduction and review
- First 4 weeks
- 2.5 mg once weekly
- After introduction
- 5 mg once weekly
- Further increases
- Only as prescribed, after at least 4 weeks on the current dose
The starting 2.5 mg dose is for initiation. Subsequent dose selection depends on response and tolerability; not everyone needs the highest dose.
Your dose is a clinical decision.
Never increase, restart, switch, or combine medications using this page. Ask your prescriber about missed doses, persistent side effects, and the next review. Milligrams are not syringe “units”; confirm your exact product, concentration, and instructions before use. SlimGLO does not direct titration or provide medical monitoring.
BEFORE YOU BEGIN
Benefits deserve
a safety conversation.
Side effects & important risks
Nausea, vomiting, diarrhea, constipation, and abdominal discomfort can occur. Review the product’s full Medication Guide with your clinician.
Important risks include pancreatitis, gallbladder problems, dehydration-related kidney injury, and severe gastrointestinal symptoms. Low blood sugar risk increases with insulin or certain diabetes medicines. Tell your clinician about all medicines and planned anesthesia or sedation.
These products carry a boxed warning about thyroid C-cell tumors in animals; human relevance is unknown. They are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2.
Seek urgent medical care for severe or persistent abdominal pain, inability to keep fluids down, or signs of dehydration. Trouble breathing or swelling of the face or throat requires emergency help. Do not wait for a monthly coaching visit.
Women’s health & pregnancy planning
Weight-loss treatment is not appropriate during pregnancy. Discuss pregnancy plans and breastfeeding before treatment; contact your prescriber promptly if pregnant.
Wegovy labeling advises stopping at least two months before a planned pregnancy. Plan this with your clinician.
Tirzepatide can reduce oral hormonal contraceptive effectiveness. Zepbound labeling advises a non-oral method or added barrier contraception for four weeks after starting and four weeks after each dose increase. Discuss your options with your prescribing clinician.
Discuss your medical history, including digestive problems and diabetes-related eye disease, before selecting treatment.
Medication sourcing & clinical references
Compounded medicines are not FDA-approved and are not interchangeable with approved products. FDA has reported dosing errors with compounded GLP-1 injections. Confirm prescription authorization and individualized dosing instructions before use.
Educational content checked October 5, 2026. Labels may change. Your current prescription and product instructions take priority.
LET’S BUILD YOUR NEXT CHAPTER
Your goals deserve
a thoughtful plan.
Start with a conversation about your goals and the support that fits your life.
Book a Consultation